Plasma pentraxin-3 and coagulation and fibrinolysis variables during acute Puumala hantavirus infection and associated thrombocytopenia

Blood Coagul Fibrinolysis. 2014 Sep;25(6):612-7. doi: 10.1097/MBC.0000000000000117.

Abstract

Thrombocytopenia and altered coagulation characterize all hantavirus infections. To further assess the newly discovered predictive biomarkers of disease severity during acute Puumala virus (PUUV) infection, we studied the associations between them and the variables reflecting coagulation, fibrinolysis and endothelial activation. Nineteen hospital-treated patients with serologically confirmed acute PUUV infection were included. Acutely, plasma levels of pentraxin-3 (PTX3), cell-free DNA (cf-DNA), complement components SC5b-9 and C3 and interleukin-6 (IL-6) were recorded as well as platelet ligands and markers of coagulation and fibrinolysis. High values of plasma PTX3 associated with thrombin formation (prothrombin fragments F1+2; r = 0.46, P = 0.05), consumption of platelet ligand fibrinogen (r = -0.70, P < 0.001) and natural anticoagulants antithrombin (AT) (r = -0.74, P < 0.001), protein C (r = -0.77, P < 0.001) and protein S free antigen (r = -0.81, P < 0.001) and a decreased endothelial marker ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 domain 13) (r = -0.48, P = 0.04). Plasma level of AT associated with C3 (r = 0.76, P < 0.001), IL-6 (r = -0.56, P = 0.01) and cf-DNA (r = -0.47, P = 0.04). High cf-DNA coincided with increased prothrombin fragments F1+2 (r = 0.47, P = 0.04). Low C3 levels reflecting the activation of complement system through the alternative route predicted loss of all natural anticoagulants (for protein C r = 0.53, P = 0.03 and for protein S free antigen r = 0.64, P = 0.004). Variables depicting altered coagulation follow the new predictive biomarkers of disease severity, especially PTX3, in acute PUUV infection. The findings are consistent with the previous observations of these biomarkers also being predictive for low platelet count and underline the cross-talk of inflammation and coagulation systems in acute PUUV infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADAM Proteins / blood
  • ADAMTS13 Protein
  • Acute Disease
  • Adult
  • Antithrombin III / metabolism
  • Biomarkers / blood
  • Blood Coagulation*
  • C-Reactive Protein / metabolism*
  • Complement C3 / metabolism
  • Complement Membrane Attack Complex / metabolism
  • DNA / blood
  • Female
  • Fibrinogen / metabolism
  • Hemorrhagic Fever with Renal Syndrome / blood*
  • Hemorrhagic Fever with Renal Syndrome / complications
  • Hemorrhagic Fever with Renal Syndrome / diagnosis
  • Hemorrhagic Fever with Renal Syndrome / virology
  • Humans
  • Interleukin-6 / blood
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Protein C / metabolism
  • Protein S / metabolism
  • Puumala virus / physiology
  • Serum Amyloid P-Component / metabolism*
  • Severity of Illness Index
  • Thrombin / metabolism
  • Thrombocytopenia / blood*
  • Thrombocytopenia / complications
  • Thrombocytopenia / diagnosis
  • Thrombocytopenia / virology

Substances

  • Biomarkers
  • Complement C3
  • Complement Membrane Attack Complex
  • IL6 protein, human
  • Interleukin-6
  • Protein C
  • Protein S
  • SC5b-9 protein complex
  • Serum Amyloid P-Component
  • PTX3 protein
  • Antithrombin III
  • Fibrinogen
  • C-Reactive Protein
  • DNA
  • Thrombin
  • ADAM Proteins
  • ADAMTS13 Protein
  • ADAMTS13 protein, human